
Pulmonx Corporation
Pulmonx Corporation(LUNG)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · LUNG · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
53
近12个月
买卖比
0.02
Buy/Sell (by trades)
整体情绪
Pulmonx Corporation内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
LUNG 季度内部人买卖趋势
LUNG 内幕交易卖出 · LUNG 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · LUNG CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
LUNG 高管卖出股份 · LUNG 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 2, 2026 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Award | 175,000 | — | Form 4 |
| Mar 2, 2026 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | 756 | $1K | Form 4 |
| Mar 2, 2026 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | 3,068 | $4K | Form 4 |
| Mar 2, 2026 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | 2,461 | $4K | Form 4 |
| Mar 2, 2026 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sale | 4,198 | $6K | Form 4 |
| Mar 2, 2026 | French Glendon E. III President and CEO · Director | Sale | 2,708 | $4K | Form 4 |
| Mar 2, 2026 | French Glendon E. III President and CEO · Director | Sale | 6,737 | $10K | Form 4 |
| Mar 2, 2026 | French Glendon E. III President and CEO · Director | Sale | 58,368 | $83K | Form 4 |
| Mar 2, 2026 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Award | 100,000 | — | Form 4 |
| Mar 2, 2026 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 835 | $1K | Form 4 |
| Mar 2, 2026 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 2,125 | $3K | Form 4 |
| Mar 2, 2026 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 1,861 | $3K | Form 4 |
| Mar 2, 2026 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 2,911 | $4K | Form 4 |
| Mar 2, 2026 | Lehman David Aaron GENERAL COUNSEL | Award | 150,000 | — | Form 4 |
| Mar 2, 2026 | Lehman David Aaron GENERAL COUNSEL | Sale | 1,163 | $2K | Form 4 |
| Mar 2, 2026 | Lehman David Aaron GENERAL COUNSEL | Sale | 4,433 | $6K | Form 4 |
| Mar 2, 2026 | Lehman David Aaron GENERAL COUNSEL | Sale | 2,590 | $4K | Form 4 |
| Mar 2, 2026 | Lehman David Aaron GENERAL COUNSEL | Sale | 4,051 | $6K | Form 4 |
| Dec 8, 2025 | Florin Daniel P Director | Sale | 23,321 | $46K | Form 4 |
| Dec 1, 2025 | French Glendon E. III President and CEO · Director | Award | 1,200,000 | — | Form 4 |
| Dec 1, 2025 | French Glendon E. III President and CEO · Director | Sale | 2,524 | $4K | Form 4 |
| Dec 1, 2025 | French Glendon E. III President and CEO · Director | Sale | 6,281 | $10K | Form 4 |
| Dec 1, 2025 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 683 | $1K | Form 4 |
| Dec 1, 2025 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 1,738 | $3K | Form 4 |
| Dec 1, 2025 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | 1,522 | $2K | Form 4 |
Radhakrishnan Srikanth
Chief Science &Techn. Officer
日期
Mar 2
股数
175,000
均价
—
总金额
—
Radhakrishnan Srikanth
Chief Science &Techn. Officer
日期
Mar 2
股数
756
均价
$1.43
总金额
$1K
Radhakrishnan Srikanth
Chief Science &Techn. Officer
日期
Mar 2
股数
3,068
均价
$1.43
总金额
$4K
Radhakrishnan Srikanth
Chief Science &Techn. Officer
日期
Mar 2
股数
2,461
均价
$1.43
总金额
$4K
Radhakrishnan Srikanth
Chief Science &Techn. Officer
日期
Mar 2
股数
4,198
均价
$1.43
总金额
$6K
French Glendon E. III
President and CEO · Director
日期
Mar 2
股数
2,708
均价
$1.43
总金额
$4K
French Glendon E. III
President and CEO · Director
日期
Mar 2
股数
6,737
均价
$1.43
总金额
$10K
French Glendon E. III
President and CEO · Director
日期
Mar 2
股数
58,368
均价
$1.43
总金额
$83K
French Glendon E. III
President and CEO · Director
日期
Dec 1
股数
1,200,000
均价
—
总金额
—
French Glendon E. III
President and CEO · Director
日期
Dec 1
股数
2,524
均价
$1.57
总金额
$4K
French Glendon E. III
President and CEO · Director
日期
Dec 1
股数
6,281
均价
$1.57
总金额
$10K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 LUNG 内幕交易
LUNG 内幕交易
Pulmonx Corporation(LUNG)内幕交易数据来源于公司内部人(包括Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER), Lehman David Aaron (GENERAL COUNSEL), French Glendon E. III (President and CEO · Director))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。LUNG内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Pulmonx Corporation机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
LUNG 内幕交易 · 5个问题Pulmonx Corporation(LUNG)的内部人包括高管和董事,如Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER), Lehman David Aaron (GENERAL COUNSEL), French Glendon E. III (President and CEO · Director)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026